24 Nov ConSalud .es
Ciencia e Innovación destina un millón de euros para estudiar biomarcadores de tumores cerebrales ...
Author: laminar
20 Nov We’ve been awarded €1M grant by the Ministry of Science to study brain tumor biomarkers with Fundación Rioja Salud and the University of the Balearic Islands
The Spanish government has announced the public grants corresponding to the State Program for research, development and innovation call — geared towards societal challenges and called "Collaboration Challenges of the year 2019". These are instruments to help meet the needs of the Spanish Science, Technology...
20 Nov Spanish biotech company Laminar, the Fundación Rioja Salud and the University of the Balearic Islands will receive one million euros from the Ministry of Science and Innovation to study brain tumor biomarkers
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text] From the left, top: Adrian McNicholl, Gema Malet, Pablo V. Escribá, Ignacio Larrayoz, Paula Fernández y Roberto Beteta. Seated: Emilce Cano, Rafael Peláez, Catalina Rosselló, Raquel Rodríguez y Manuel Torres. November 20th, 2020 The Spanish government has announced...
19 Nov The versatility of melitherapy
Many drugs that are available in the market have something in common, regarding how they make effect: they directly target one or more proteins. And this is not a coincidence. Proteins perform a vast range of functions within the cells of all living organisms that...
30 Oct Our team’s review on Membrane Lipid Composition is widely discussed by the scientific community
A recent review article published by Laminar Pharma scientists in IJMS has awoken the interest of the scientific community....
16 Oct Melitherapy: When the surface has deep implications
Many drugs that are available in the market have something in common, regarding how they make effect: they directly target one or more proteins. And this is not a coincidence. Proteins perform a vast range of functions within the cells of all living organisms that...
14 Sep PlantaDoce
Laminar Pharma abre ronda de cinco millones para dar su salto al MAB ...
05 Sep PlantaDoce
Laminar Pharma abre ronda de cinco millones para dar su salto al MAB ...
22 Jul Spanish biotechnology company Laminar Pharma joins the Growth segment of the Pre-Market Environment, in a step towards joining the stock market
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]Given the good track record of the stock market as an alternative source of financing, the biotechnology company Laminar Pharma is taking its first steps to attract private investors and institutions, by joining...
21 Jul Bioib
La biotecnológica balear Laminar Pharmaceuticals se acerca al Mercado Alternativo Bursátil ...